Literature DB >> 31911571

Visualization of exceptional crosssectional en-face views of pulmonary and tricuspid valves using 2D transthoracic echocardiography in patients with pulmonary hypertension.

Ibrahim Başarıcı1.   

Abstract

Entities:  

Year:  2020        PMID: 31911571      PMCID: PMC7141425          DOI: 10.14744/AnatolJCardiol.2019.96165

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.
Cross-sectional 2D transthoracic echocardiographic (TTE) images of pulmonary and tricuspid valves depicting three leaflets simultaneously are seldom visualized in adults and are deemed to be impossible to obtain using 2D TTE. Recently, therapeutic advancements have been achieved for different pathologies of both valves. However, anatomical obstacles due to retrosternal placement and crescent shape of the right ventricle and neighboring of the left upper lung lobe to the pulmonary trunk detain comprehensive evaluation of tricuspid and pulmonary valves. Generally, short-axis en-face views cannot be obtained using 2D TTE. Lack of this morphological data requires complimentary advanced imaging techniques. However, some cardiovascular diseases yield extensive remodeling, wherein unexpected anatomical structures or infrequent projections of ordinary structures can be visualized. Pulmonary arterial hypertension (PAH) offers an opportunity to obtain these rare views, which is facilitated by dilatation of the right ventricle and pulmonary trunk. Here, we present exceptional cross-sectional en-face views of pulmonary and tricuspid valves in patients with PAH of various etiologies. Figure 1 shows en-face views of the pulmonary valve in patients with concomitant chronic thromboembolic pulmonary hypertension and residual PAH following congenital heart disease surgery (Video 1), idiopathic PAH (Video 2), and secondary PAH due to unoperated ventricular septal defect and patent ductus arteriosus, respectively. Figure 2 shows en-face views of the tricuspid valve in patients with pulmonary veno-occlusive disease, residual PAH following the closure of patent ductus arteriosus (Video 3), and secondary PAH due to unoperated ventricular and atrial septal defects, respectively.
Figure 1

Modified parasternal short-axis view reveals the open (right panels) and closed (left panels) tricuspid structures of the pulmonary valve resembling the “Mercedes sign” of the aortic cusp in the closed state. Ultimate diagnoses of the patients are as follows: concomitant chronic thromboembolic pulmonary hypertension and residual PAH following congenital heart disease [details of the defect and surgery are unknown] corrective surgery (Fig. 1a; Video 1), idiopathic PAH (Fig. 1b; Video 2), and secondary PAH due to unoperated ventricular septal defect (Fig. 1c) and patent ductus arteriosus (Fig. 1d) AO - aortic valve; PV - pulmonary valve; LA - left atrium; LAA - left atrial appendage; LV - left ventricle; A, R, L - anterior, right, and left cusps of the pulmonary valve, respectively; arrow indicates the origin of the left main coronary artery, and arrow heads indicate the mitral valve

Figure 2

Modifying the standard projections by slight tilting and excursion of the transducer; along with the mitral valve, parasternal cross-sectional short-axis views (closed states in left panels, open states in right panels) of the tricuspid valve could be obtained in patients with PAH. Representative cases were diagnosed with pulmonary veno-occlusive disease (Fig. 2a), residual PAH following the closure of patent ductus arteriosus (Fig. 2b; Video 3), and secondary PAH due to unoperated ventricular (Fig. 2c) and atrial (Fig. 2d) septal defects, respectively

TV - tricuspid valve; MV - mitral valve; S, A, P - septal, anterior, and posterior cusps of the tricuspid valve, respectively; AP -anterior and posterior cusps of the mitral valve, respectively; arrows indicate the interventricular septum, and asterisk indicates the ventricular septal defect

Modified parasternal short-axis view reveals the open (right panels) and closed (left panels) tricuspid structures of the pulmonary valve resembling the “Mercedes sign” of the aortic cusp in the closed state. Ultimate diagnoses of the patients are as follows: concomitant chronic thromboembolic pulmonary hypertension and residual PAH following congenital heart disease [details of the defect and surgery are unknown] corrective surgery (Fig. 1a; Video 1), idiopathic PAH (Fig. 1b; Video 2), and secondary PAH due to unoperated ventricular septal defect (Fig. 1c) and patent ductus arteriosus (Fig. 1d) AO - aortic valve; PV - pulmonary valve; LA - left atrium; LAA - left atrial appendage; LV - left ventricle; A, R, L - anterior, right, and left cusps of the pulmonary valve, respectively; arrow indicates the origin of the left main coronary artery, and arrow heads indicate the mitral valve Modifying the standard projections by slight tilting and excursion of the transducer; along with the mitral valve, parasternal cross-sectional short-axis views (closed states in left panels, open states in right panels) of the tricuspid valve could be obtained in patients with PAH. Representative cases were diagnosed with pulmonary veno-occlusive disease (Fig. 2a), residual PAH following the closure of patent ductus arteriosus (Fig. 2b; Video 3), and secondary PAH due to unoperated ventricular (Fig. 2c) and atrial (Fig. 2d) septal defects, respectively TV - tricuspid valve; MV - mitral valve; S, A, P - septal, anterior, and posterior cusps of the tricuspid valve, respectively; AP -anterior and posterior cusps of the mitral valve, respectively; arrows indicate the interventricular septum, and asterisk indicates the ventricular septal defect Due to abovementioned anatomical obstacles, it is extremely difficult to obtain cross-sectional en-face images of pulmonary and tricuspid valves using 2D TTE. Unfortunately, echocardiography textbooks lack sample representative images. While 3D echocardiography has become a valuable tool to overcome this drawback, we must realize that extensive remodeling of the right side of the heart in certain diseases may facilitate 2D visualization of these unexpected views. Literature is also limited about this issue. En-face view of the pulmonary valve using 2D TTE has been reported just once (1). According to a recent paper attempting to obtain en-face view of the tricuspid valves, adequate images could be obtained by subcostal views in only 58% cases using 2D TTE (2). Therefore, we conclude that simply by modifying the standard parasternal projections of routine 2D TTE examination, we for the first time demonstrate that it is possible to obtain exceptional cross-sectional en-face views of pulmonary and tricuspid valves in selected patients with advanced PAH.

Video 1

Video displays short-axis cross-sectional view of the tricuspid structure of the pulmonary valve (simultaneous Mercedes sign along with the aortic valve is notable) of a patient who was finally diagnosed with concomitant residual PAH following congenital heart disease correction surgery (details of the defect are unknown) and chronic thromboembolic pulmonary hypertension (obtained by modified parasternal short-axis view)

Video 2

Video displays the tricuspid structure of the pulmonary valve in a patient diagnosed with idiopathic PAH (obtained by modified parasternal short-axis view)

Video 3

Video displays short-axis cross-sectional en-face view of the tricuspid valve (along with the bicuspid mitral valve) at parasternal short-axis in a patient with residual PAH following the closure of patent ductus arteriosus
  2 in total

1.  Incremental value of the en face view of the tricuspid valve by two-dimensional and three-dimensional echocardiography for accurate identification of tricuspid valve leaflets.

Authors:  Ivan Stankovic; Ana Maria Daraban; Ruta Jasaityte; Aleksandar N Neskovic; Piet Claus; Jens-Uwe Voigt
Journal:  J Am Soc Echocardiogr       Date:  2014-01-31       Impact factor: 5.251

2.  Unusual echocardiographic views of bicuspid and tricuspid pulmonic valves.

Authors:  E McAleer; S Kort; B P Rosenzweig; E S Katz; P A Tunick; C K Phoon; I Kronzon
Journal:  J Am Soc Echocardiogr       Date:  2001-10       Impact factor: 5.251

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.